Related Experiment Video
Updated: Feb 6, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
Andrew T Ludlow1,2, Mandy Sze Wong3,4, Jerome D Robin3,5
1Department of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390, USA. atludlow@umich.edu.
Abstract:
Alternative splicing is dysregulated in cancer and the reactivation of telomerase involves the splicing of TERT transcripts to produce full-length (FL) TERT. Knowledge about the splicing factors that enhance or silence FL hTERT is lacking. We identified splicing factors that reduced telomerase activity and shortened telomeres using a siRNA minigene reporter screen and a lung cancer cell bioinformatics approach. A lead candidate, NOVA1, when knocked down resulted in a shift in hTERT splicing to non-catalytic isoforms, reduced telomerase activity, and progressive telomere shortening. NOVA1 knockdown also significantly altered cancer cell growth in vitro and in xenografts. Genome engineering experiments reveal that NOVA1 promotes the inclusion of exons in the reverse transcriptase domain of hTERT resulting in the production of FL hTERT transcripts. Utilizing hTERT splicing as a model splicing event in cancer may provide new insights into potentially targetable dysregulated splicing factors in cancer.
Insights
Alternative splicing dysregulation in cancer impacts telomerase reactivation. NOVA1 knockdown shifts hTERT splicing, reducing telomerase activity and cancer cell growth, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Alternative splicing is frequently dysregulated in cancer.
- Telomerase reactivation in cancer involves splicing of TERT transcripts to produce full-length (FL) TERT.
- Splicing factors that regulate FL hTERT production are not well understood.
Purpose of the Study:
- To identify splicing factors that regulate telomerase activity and telomere length.
- To investigate the role of NOVA1 in hTERT splicing and cancer progression.
Main Methods:
- Conducted a siRNA minigene reporter screen to identify splicing factors.
- Utilized a lung cancer cell bioinformatics approach.
- Performed genome engineering experiments to validate NOVA1 function.
Main Results:
- Identified NOVA1 as a key splicing factor that promotes FL hTERT production.
- NOVA1 knockdown shifted hTERT splicing to non-catalytic isoforms, reduced telomerase activity, and shortened telomeres.
- NOVA1 knockdown inhibited cancer cell growth in vitro and in xenografts.
Conclusions:
- NOVA1 promotes exon inclusion in the hTERT reverse transcriptase domain, leading to FL hTERT transcripts.
- Targeting dysregulated splicing factors like NOVA1 may offer novel therapeutic strategies for cancer.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Hematopoietic Stem Cells
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

